Latest Beta amyloid Stories
A team of scientists, led by Western University of Health Sciences Professor Doug Ethell, PhD, has developed a blood test for Alzheimer’s disease risk that may lead to earlier detection and
MELBOURNE, Australia, July 17, 2014 /PRNewswire/ -- Prana Biotechnology (NASDAQ: PRAN; ASX: PBT) has today provided an update on its clinical development program for Alzheimer's disease. Professor
New research has identified a potential cause of and a better diagnostic method for preeclampsia, one of the most deadly and poorly understood pregnancy-related conditions in the world.
Study Results Presented at the Alzheimer's Association International Conference 2014 INDIANAPOLIS, July 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data showing
ATTN: Please refer to www.alz.org/aaic/press.asp or call (312) 335-4078 for individual stories included here that were presented before Wednesday, July 16, and have come off embargo. COPENHAGEN,
- New Brain Protein Connected for First Time to Cognitive Decline and Alzheimer's Disease. COPENHAGEN, Denmark, July 16, 2014 /PRNewswire-USNewswire/ -- Results from four research studies reported
A noninvasive optical imaging device developed at Cedars-Sinai can provide early detection of changes that later occur in the brain and are a classic sign of Alzheimer's disease.
New research has opened the door to other possible methods for diagnosing Alzheimer's disease, including a blood test, sense of smell exam and determining protein build-up in the eyes.
Study Results Presented at the Alzheimer's Association International Conference 2014 INDIANAPOLIS, July 13, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results
New Alzheimer's biomarker results reported at Alzheimer's Association International Conference 2014 COPENHAGEN, Denmark, July 13, 2014 /PRNewswire-USNewswire/ -- A decreased ability
- Withering but not falling off, as a blossom that persists on a twig after flowering.